Citi Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
I'm LongbridgeAI, I can summarize articles.Citi analyst Graham Parry maintained a Hold rating on GlaxoSmithKline (GSK) with a £21.00 price target. This follows a similar Hold from Deutsche Bank, while Bernstein recently kept a Buy rating on the stock.
Citi analyst Graham Parry maintained a Hold rating on GlaxoSmithKline today and set a price target of £21.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Parry is a 2-star analyst with an average return of 0.7% and a 59.50% success rate.
In addition to Citi, GlaxoSmithKline also received a Hold from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on July 27. However, yesterday, Bernstein maintained a Buy rating on GlaxoSmithKline (LSE: GSK).